Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin

Journal of Liposome Research

Volumn 23, Issue 1, 2013, Pages 28-36

  Kamel, Rabab ^a   Basha, Mona ^a   Abd El Alim, Sameh H ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Gelucire ; Hemorrhoids; Proniosomes; Rectal; Rutin; Span

Indexed keywords

GELUCIRE; MACROGOL DERIVATIVE; NONIONIC SURFACTANT; RUTOSIDE; SORBITAN STEARATE;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; ENCAPSULATION; EX VIVO STUDY; FEASIBILITY STUDY; GEL; MALE; MOLECULAR STABILITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RECTAL DRUG ADMINISTRATION; RECTUM; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, RECTAL; ANIMALS; DRUG DELIVERY SYSTEMS; FATS; FATTY ACIDS; HEMORRHOIDS; HEXOSES; HUMANS; LIPOSOMES; OILS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; RUTIN;

EID: 84873286344     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.727422     Document Type: Article

References (46)

1. Alsarra, I. A. (2009). Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. J Microencapsul 26:272-278.
2. Alsarra, I. A., Bosela, A. A., Ahmed, S. M., Mahrous, G. M. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485-490. (Pubitemid 40342523)
3. Ammar, H. O., Ghorab, M., El-Nahhas, S. A., Kamel, R. (2009). Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation. AAPS PharmSciTech 10:7-20.
4. Arunothayanun, P., Bernard, M. S., Craig, D. Q., Uchegbu, I. F., Florence, A. T. (2000). The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm 201:7-14. (Pubitemid 30364965)
5. Aungst, B. J., Rogers, N. J., Shefter, E. (1988). Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther 244:23-27. (Pubitemid 18042357)
6. Baillie, A. J., Coombs, G. H., Dolan, T. F., Laurie, J. (1986). Non-ionic surfactant vesicles, niosomes, as a delivery system for the antileishmanial drug, sodium stibogluconate. J Pharm Pharmacol 38:502-505. (Pubitemid 16081869)
7. Bangham, A. D., Horne, R. W. (1964). Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660-668.
8. Barr, W. H. Riegelman, S. (1970). Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. J Pharm Sci 59:154-163.
9. Bayindir, Z. S., Yuksel, N. (2010). Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049-2060.
10. Block, L. (2005). Medicated topicals. In: Beringer, P. (Ed.), Remington: the science and practice of pharmacy, 21st ed. (pp. 877-880). Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins.
11. Brandl, M. (2001). Liposomes as drug carriers: a technological approach. Biotechnol Ann Rev 7:59-85. (Pubitemid 41081525)
12. Calabro, M. L., Tommasini, S., Donato, P., Stancanelli, R., Raneri, D., Catania, S., et al. (2005). The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays. J Pharm Biomed Anal 36:1019-1027. (Pubitemid 40037822)
13. Cevc, G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675-711. (Pubitemid 38326939)
14. De Logu, A.F., A.M. Anchisi, C. Maccioni, A.M. Sinico, C. and Schivo, M.L., (1997). Effects of activity of miconazole and ketoconazole in phospholipids formulations. J Antimicrob Chemother 40, 889-893. (Pubitemid 28022157)
15. Desai, A., Lee, M. (2007). Gibaldi's Drug Delivery Systems in Pharmaceutical care. Chapter 7. Rectal, Vaginal and Uretheral Delivery., pp. 95-100.
16. El-Laithy, H.M., Shoukry, O., Mahran, L.G. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 77, 43-55.
17. El-Leithy, E.S., Shaker, D.S., Ghorab, M.K., Abdel-Rashid, R.S., (2010). Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration. AAPS PharmSciTech 11, 1695-1702.
18. Erjavec, V., Pavlica, Z., Sentjurc, M., Petelin, M., (2006). In vivo study of liposomes as drug carriers to oral mucosa using EPR oximetry. Int J Pharm 307, 1-8. (Pubitemid 41773245)
19. Fang, J.Y., Yu, S.Y., Wu, P.C., Huang, Y.B., Tsai, Y.H., (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215, 91-99.
20. Felt-Bersma, R.J., Bartelsman, J.F., (2009). Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae and sexually transmitted diseases. Best practice & research 23, 575-592.
21. Gohel, M., Panchal, M., Jogani, V., (2000). Novel mathematical method for quantitative expression of deviation from the Higuchi model. AAPS Pharm. Sci. Technol. 1, 43-48.
22. Griffin, W.C., (1949). Classification of surface-active agents by "HLB". J Soc Cosmetic Chem 1, 311-326.
23. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials 24, 4283-4300. (Pubitemid 36814076)
24. Hu, C., Rhodes, D.G., (1999). Proniosomes: a novel drug carrier preparation. Int J Pharm 185, 23-35. (Pubitemid 29333093)
25. Hu, C., Rhodes, D.G., (2000). Proniosomes: a novel drug carrier preparation. Int J Pharm 206, 110-122.
26. Ibrahim, M. M., Sammour, O. A., Hammad, M. A., Megrab, N. A. (2008). In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS PharmSciTech 9:782-790.
27. Junyaprasert, V. B., Singhsa, P., Suksiriworapong, J., Chantasart, D. (2012). Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm 423:303-311.
28. Junyaprasert, V. B., Teeranachaideekul, V., Supaperm, T. (2008). Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech 9:851-859.
29. Lacy, B. E., Weiser, K. (2009). Common anorectal disorders: diagnosis and treatment. Curr Gastroenterol Rep 11:413-419.
30. Mainardes, R. M., Urban, M. C., Cinto, P. O., Chaud, M. V., Evangelista, R. C., Gremiao, M. P. (2006). Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 3:275-285. (Pubitemid 44031626)
31. Matsuda, H., Arima, H. (1996). Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev 36:81-99. (Pubitemid 29074478)
32. Miyake, K., Arima, H., Hirayama, F., Yamamoto, M., Horikawa, T., Sumiyoshi, H., et al. (2000). Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropylbeta- cyclodextrin. Pharm Dev Technol 5:399-407. (Pubitemid 30602848)
33. Mokhtar, M., Sammour, O. A., Hammad, M. A., Megrab, N. A. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104-111.
34. Nakada, Y., Awata, N., Ikuta, Y., Goto, S. (1989). The effect of bile salts on the oral mucosal absorption of human calcitonin in rats. J Pharmacobiodyn 12:736-743. (Pubitemid 20086047)
35. Nasr, M. (2010). In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration. AAPS PharmSciTech 11:85-89.
36. Patel, D. M., Patel, N. M., Patel, V. F., Bhatt, D. A. (2007). Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS PharmSciTech 8:Article 30
37. Perrett, S., Golding, M., Williams, W. P. (1991). A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J Pharm Pharmacol 43:154-161.
38. Shahiwala, A., Misra, A. (2002). Studies in topical application of niosomally entrapped Nimesulide. J Pharm Pharm Sci 5:220-225. (Pubitemid 37211713)
39. Shaikh, K. S., Chellampillai, B., Pawar, A. P. (2010). Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm 36:946-953.
40. Siegel, I. A., Gordon, H. P. (1985). Effects of surfactants on the permeability of canine oral mucosa in vitro. Toxicol Lett 26:153-158. (Pubitemid 16251053)
41. Solanki, A. B., Parikh, J. R., Parikh, R. H. (2007). Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box- Behnken design. AAPS PharmSciTech 8:E86.
42. Uchegbu, I. F., Florence, A. T. (1995). Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Coll Interf Sci 58:1-55.
43. Uchegbu, I. F., Vyas, S. P. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33-70. (Pubitemid 28430243)
44. Vora, B., Khopade, A. J., Jain, N. K. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release 54:149-165. (Pubitemid 28342694)
45. Yonezawa, Y., Ishida, S., Sunada, H. (2001). Release from or through a wax matrix system. I. Basic release properties of the wax matrix system. Chem Pharm Bull 49:1448-1451. (Pubitemid 33043275)
46. Yoshioka, T., Sternberg, B., Florence, A. T. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1-6. (Pubitemid 24087666)